Lippoldt Darin
SEC CIK 1504783 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | CLO | 59.2K | — | $19.89M | 52 | 2021-12-10 | 2026-09-11 |
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
Transactions 52
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 17:06 | 2026-09-11 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | A - Grant | $0.00 | +4,483 | 59.2K | +8% | $0 | |
| 2026-09-15 17:06 | 2026-09-11 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | F - Tax | $156.22 | -2,419 | 56.8K | -4% | -$377.9K | |
| DT | 2026-07-13 16:27 | 2026-07-09 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $81.49 | +10.0K | 64.7K | +18% | +$814.9K |
| DT | 2026-07-13 16:27 | 2026-07-09 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $179.60 | -10.0K | 54.7K | -15% | -$1.80M |
| DMT | 2026-06-30 16:52 | 2026-06-26+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $81.49 | +10.0K | 56.4K | +22% | +$814.9K |
| DMT | 2026-06-30 16:52 | 2026-06-26+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $170.15 | -10.0K | 54.7K | -15% | -$1.70M |
| DM | 2026-02-17 | 2026-02-12+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $0.00 | +5,892 | 49.6K | +13% | $0 |
| DM | 2026-02-17 | 2026-02-12+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | F - Tax | $124.00 | -8,558 | 50.5K | -14% | -$1.06M |
| D | 2026-02-17 | 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | A - Grant | $0.00 | +9,968 | 60.5K | +20% | $0 |
| D | 2026-02-17 | 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | G - Gift | $0.00 | -365 | 54.7K | -0.7% | $0 |
| D | 2026-02-03 | 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | F - Tax | $136.06 | -1,335 | 47.8K | -3% | -$181.6K |
| D | 2026-02-03 | 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $0.00 | +2,373 | 49.1K | +5% | $0 |
| D | 2026-01-12 | 2026-01-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $35.99 | +3,349 | 46.8K | +8% | +$120.5K |
| D | 2025-12-10 | 2025-12-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +4,376 | 47.8K | +10% | +$189.2K |
| D | 2025-12-10 | 2025-12-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $159.65 | -4,376 | 43.4K | -9% | -$698.6K |
| DM | 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $0.00 | +4,100 | 44.5K | +10% | $0 |
| DM | 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $116.76 | -2,184 | 43.4K | -5% | -$255.0K |
| D | 2025-02-14 | 2025-02-12 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | G - Gift | $0.00 | -190 | 41.5K | -0.5% | $0 |
| D | 2025-02-12 | 2025-02-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $0.00 | +1,727 | 42.6K | +4% | $0 |
| D | 2025-02-12 | 2025-02-10 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $118.25 | -911 | 41.7K | -2% | -$107.7K |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $0.00 | +2,373 | 42.1K | +6% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $152.91 | -1,250 | 40.9K | -3% | -$191.1K |
| D | 2024-08-05 | 2024-08-01 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $154.01 | -2,996 | 39.7K | -7% | -$461.4K |
| D | 2024-08-05 | 2024-08-01 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $79.02 | +2,996 | 42.7K | +8% | +$236.7K |
| D | 2024-07-18 | 2024-07-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $79.02 | +7,004 | 46.7K | +18% | +$553.5K |
| D | 2024-07-18 | 2024-07-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $150.00 | -7,004 | 39.7K | -15% | -$1.05M |
| D | 2024-02-15 | 2024-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $132.99 | -1,098 | 39.7K | -3% | -$146.0K |
| M | 2024-02-08 | 2024-02-06+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $138.47 | -1,952 | 37.9K | -5% | -$270.3K |
| 2024-02-02 | 2024-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $140.65 | -1,250 | 37.0K | -3% | -$175.8K | |
| D | 2024-01-24 | 2024-01-22 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $139.86 | -10.0K | 35.9K | -22% | -$1.40M |
| D | 2024-01-24 | 2024-01-22 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $79.02 | +10.0K | 45.9K | +28% | +$790.2K |
| D | 2023-12-08 | 2023-12-06 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +20.8K | 56.7K | +58% | +$900.7K |
| D | 2023-12-08 | 2023-12-06 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $119.86 | -20.8K | 35.9K | -37% | -$2.50M |
| 2023-11-29 | 2023-11-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $112.27 | -10.9K | 35.9K | -23% | -$1.23M | |
| 2023-09-01 | 2023-08-30 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | G - Gift | $0.00 | -190 | 46.8K | -0.4% | $0 | |
| 2023-08-23 | 2023-08-21 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $107.39 | -2,132 | 47.0K | -4% | -$229.0K | |
| M | 2023-02-08 | 2023-02-06+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $102.71 | -16.3K | 32.7K | -33% | -$1.67M |
| 2023-02-02 | 2023-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $109.97 | -1,250 | 30.4K | -4% | -$137.5K | |
| D | 2022-11-10 | 2022-11-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $125.04 | -5,082 | 29.2K | -15% | -$635.5K |
| D | 2022-11-10 | 2022-11-08 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +5,082 | 34.3K | +17% | +$219.7K |
| D | 2022-11-04 | 2022-11-03 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $125.02 | -4,518 | 29.2K | -13% | -$564.8K |
| D | 2022-11-04 | 2022-11-03 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +4,518 | 33.8K | +15% | +$195.4K |
| DM | 2022-11-02 | 2022-11-01+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $120.28 | -10.4K | 29.2K | -26% | -$1.25M |
| DM | 2022-11-02 | 2022-11-01+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.4K | 39.2K | +36% | +$449.7K |
| DM | 2022-10-28 | 2022-10-26+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.0K | 34.2K | +41% | +$432.4K |
| DM | 2022-10-28 | 2022-10-26+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $115.03 | -10.0K | 29.2K | -25% | -$1.15M |
| D | 2022-10-05 | 2022-10-04 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.0K | 39.2K | +34% | +$432.4K |
| D | 2022-10-05 | 2022-10-04 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale+OE | $111.04 | -10.0K | 29.2K | -25% | -$1.11M |
| M | 2022-09-09 | 2022-09-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | G - Gift | $0.00 | -200 | 29.3K | -0.7% | $0 |
| M | 2022-03-22 | 2022-03-18+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $95.05 | -8,755 | 29.4K | -23% | -$832.1K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | S - Sale | $80.45 | -4,079 | 38.1K | -10% | -$328.2K |
| 2021-12-14 | 2021-12-10 | NBIX | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin | CLO | G - Gift | $0.00 | -120 | 34.4K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations